Drug Discovery World

APRIL 8, 2024

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. What you will learn: Where is the opportunity in the monoclonal antibody market and where is the market heading? The post Where is the opportunity in the therapeutic antibody market?

Marketing 130

Marketing Engineering Therapies Disease 130

Drug Discovery World

FEBRUARY 22, 2024

market capitalisation growth to $3.67 The top 20 global biopharmaceutical companies experienced varied year-on-year (YoY) market capitalisation shifts in 2023 amid the macroeconomic headwinds, steep patent cliffs and the commencement of US drug price negotiations under the Inflation Reduction Act (IRA).

Marketing 130

Marketing FDA Approval Biosimilars FDA 130

Drug Discovery World

FEBRUARY 20, 2024

The drug discovery informatics market is predicted to grow from $3.77 Drug discovery informatics trends The increasing prevalence of chronic diseases is anticipated to play a large part in driving the expansion of the informatics market. The post Drug discovery informatics market predicted to grow 12.6% billion in 2024 to $6.06

Marketing 130

Marketing Biosimilars Drugs Science 130

Drug Discovery World

JUNE 1, 2023

A Nature publication confirmed that there are currently 12 FDA-approved ADCs on the market, and nine of these secured FDA approval in the past six years 2. DDW’s Megan Thomas explores three trends in the market. Varying sources suggest that China has been one to watch over recent years and continues to be going forward.

Marketing 245

Marketing FDA Approval Licensing Licensing 245

Perficient: Drug Development

APRIL 16, 2024

IDC Market Glance: Payer, 2Q24 Perficient is excited to be included in the IDC Market Glance: Payer, 2Q24 (doc #US51961724, April 2024) report. According to IDC, this report “provides a glance at the current makeup of the payer IT landscape, illustrates the vendor landscape, and depicts the segments and structure of the market.”

Marketing 107

Marketing Government 107

Drug Discovery World

FEBRUARY 5, 2024

Hosted by DDW and sponsored by Astrea Biosciences “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET. Join this free webinar and learn about some of the key opportunities that are available to drug discovery and development (..)

Therapies 130

Therapies Marketing RNA Science 130

Drug Discovery World

NOVEMBER 22, 2023

The European Commission (EC) has granted marketing authorisation for YORVIPATH (palopegteriparatide) as replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism. YORVIPATH is Ascendis Pharma’s prodrug of parathyroid hormone (PTH 1-34), administered once daily.

Marketing 130

Marketing Drugs Regulations Therapies 130

Drug Discovery World

JANUARY 4, 2023

Increasing collaborations and partnerships between market players are expected to contribute to significant growth in the antibodies market between 2022 and 2030, ResearchAndMarkets.com predicts. The post Partnerships and collaborations fuel antibodies market growth appeared first on Drug Discovery World (DDW). Remember Me.

Marketing 130

Marketing Drugs 130

Drug Discovery World

APRIL 18, 2023

Sascha Fischer, Business Development Manager for Automation at Genedata looks at three critical digitalisation components that streamline the journey to market. Username or E-mail Password Remember Me Forgot Password The post Accelerating time to market through digitalisation appeared first on Drug Discovery World (DDW).

Marketing 130

Marketing Drugs 130

Drug Discovery World

FEBRUARY 28, 2023

A new strategic guide , intended to help manufacturers bring rare disease products to market, has been launched to mark Rare Disease Day (February 28). Craig Caceci, Terebellum’s Managing Director, commented: “Bringing any product to market, particularly those used to treat rare and orphan diseases is a challenge enough.

Marketing 130

Marketing Disease Production Treatment 130

Drug Discovery World

MAY 5, 2023

The US market for medicines grew by 5% in 2022, reaching a total value of $429Bn on a net price basis. This was driven by a range of factors, including an increase in health services utilisation, which is now back to pre-pandemic levels, and the entry of new medicines into the market.

Marketing 130

Marketing Biosimilars Drugs Science 130

Drug Discovery World

SEPTEMBER 28, 2023

Both GTPs and GMPs must be followed to get cell-based advanced therapies or tissue-based therapy products to market. How will not having a GMP supplier impact the speed a therapy gets to market? The post Webinar: Avoid unnecessary delays getting cell therapies to market appeared first on Drug Discovery World (DDW).

Therapies 130

Therapies Marketing Clinical Development Production 130

Drug Discovery World

OCTOBER 4, 2023

Our focus in the near term is on the registration, approval and commercialization of Kinselby in the European Union, Switzerland and the UK and we are on track to file for European Marketing Approval of Kinselby in Q1 2024, to rapidly bring this therapy into clinical use. 4SC is

Marketing 130

Marketing Treatment Therapies Disease 130

Drug Discovery World

FEBRUARY 13, 2024

In this webinar, hosted by DDW and sponsored by Astrea Bioseparations, you will learn about how market growth can be sustained to maximise on opportunities in cell and gene therapy (CGT). The post Cell & gene therapies: How can market growth be sustained to maximise on opportunities?

Therapies 130

Therapies Marketing RNA Science 130

Cytel

MAY 7, 2024

Here we explore the evolution and impact of market exclusivity policies in the EU and US, highlighting their role in fostering innovation and accessibility in rare disease treatment. Market exclusivity for orphan drugs traces back to the early 1980s in the United States, with the landmark Orphan Drug Act of 1983.

Marketing 59

Marketing Production Drugs Disease 59

ProRelix Research

NOVEMBER 2, 2023

Limited patient populations, […] The post Post-Marketing Surveillance Strategies appeared first on ProRelix Research. Although clinical trials provide useful information regarding the efficacy and safety of new drugs, biological products, and medical devices, the information captured through them is not all-encompassing.

Marketing 98

Marketing Clinical Trials Trials Production 98

Drugs.com

APRIL 4, 2024

THURSDAY, April 4, 2024 (HealthDayNews) -- Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio.

Marketing 109

Marketing Drugs Pharmaceuticals Trials 109

Drug Discovery World

JUNE 1, 2023

Using marketed treatments as a proxy, BI is expecting ex-US markets to have a 30-40% contribution within five years of launch. Shah added: “Unprecedented demand in obesity coupled with the strong relaunch of Wegovy, which serves as a benchmark for future launches, underpins our upgraded sales view for the market.

Marketing 130

Marketing Drugs Therapies Trials 130

Drug Discovery World

OCTOBER 17, 2023

Andreas Dreps DDW is delighted to confirm that ICON’s SrVP and Global Head of Science Andreas Dreps and Senior Director Muaiad Kittaneh will present a session on identifying research strategies to get to market faster. The post DDW Cancer Research Summit: Strategies to get to market faster appeared first on Drug Discovery World (DDW).

Marketing 130

Marketing Research Clinical Trials Science 130

Collaborative Drug

APRIL 19, 2024

Tokyo, Japan, April 17, 2024 — In a significant move to bolster CDD Vault’s presence in the Japanese market, Collaborative Drug Discovery (CDD) is excited to announce the appointment of Mr. Yasushi Hamagashira as the new Head of Sales and Marketing for Japan.

Marketing 103

Marketing Drugs 103

Drug Discovery World

AUGUST 14, 2023

While CGT is still an emerging market, its growth has accelerated over the last five years, resulting in a wave of products approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Driven by the rapid pace of innovation, the market for CGTs is expected to grow from $4.4 billion in 2020 to $15.5

Marketing 130

Marketing DNA Therapies FDA 130

Drug Discovery World

FEBRUARY 6, 2024

References [link] [link] [link] [link] [link] [link] [link] [link] [link] [link] [link] [link] [link] The post How digital innovation is helping therapeutics to get to market faster appeared first on Drug Discovery World (DDW).

Marketing 173

Marketing Laboratories Engineering Clinical Trials 173

Antidote

MAY 10, 2024

While it is most commonly used in relation to art generators or web searches, AI has many practical applications beyond these uses — especially within the clinical trial marketing space.

Clinical Trials 52

Clinical Trials Marketing Trials 52

Fierce BioTech

MARCH 15, 2024

Oncology Market Outlook 2024 This paper assesses the current state of the oncology market, reviewing key expectations for 2024. jpiatt Fri, 03/15/2024 - 13:46 This paper assesses the current state of the oncology market, reviewing key expectations for 2024.

Targeted Protein Degradation 52

Targeted Protein Degradation Marketing Therapies Science 52

Drug Discovery World

JULY 3, 2023

Emmanuel Abate, President of Genomic Medicine at Cytiva, said: “As pointed out in our 2023 Global Biopharma Resilience Index, collaborations are essential to solve the challenges of bringing future therapeutics to market. We feel lucky to collaborate with such a committed organisation like Cytiva in these efforts.”

Marketing 130

Marketing Therapies Virus Government 130

Drug Discovery World

FEBRUARY 21, 2023

Kristina Tatiossian , PhD, founder of Arkitekt Agency, looks at how biotech companies are currently using social media and provides a five-step guide for how to make the most of this ubiquitous marketing tool. Furthermore, marketing teams can tailor the organisation’s following to feature specific demographics.

Marketing 130

Marketing Science DNA Laboratories 130

Fierce BioTech

FEBRUARY 21, 2024

CNS Market Outlook, 2024 This paper assesses the current state of the broad CNS market, reviewing key expectations for 2024. It also provides a high-level look at the pain market and the evolving regulatory environment. It addresses Alzheimer’s disease, biomarkers, and advances in psychiatry in detail.

Marketing 52

Marketing Science Disease 52

Drug Discovery World

OCTOBER 20, 2023

The post Free clinical trial health check to bring drugs to market faster appeared first on Drug Discovery World (DDW).

Clinical Trials 162

Clinical Trials Trials Marketing Drugs 162

Drug Discovery World

NOVEMBER 8, 2022

The partnership means EIT Health will recommend PLG to early-stage b iotech start-ups requiring regulatory support to accelerate their journey to market. As well as providing funding, EIT Health’s VCoE aims to build start-ups market readiness, through valuable contacts and access to professional services. .

Marketing 130

Marketing Compliance Science Drugs 130

Perficient: Drug Development

JANUARY 16, 2024

Personalization (formerly known as Interaction Studio) is a tool that exists inside the Salesforce Marketing Cloud tenant. In this case, we want to know where the user is for marketing and statistical purposes, and not punish our user in the same way Lotso wants to catch the toys. The sitemap is the heart of personalization.

Marketing 64

Marketing Production 64

Drugs.com

MARCH 11, 2024

MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a.

Marketing 106

Marketing Trials Pharmaceuticals Drugs 106

Fierce BioTech

APRIL 10, 2024

Straight to Market in an Autoinjector The use of prefilled syringes to administer biotherapeutics is beginning to gain traction because they offer a range of stability, efficacy, and patient safety benefits.

Marketing 52

Marketing 52

Fierce BioTech

MARCH 19, 2024

Cookieless Marketing of Pharmaceuticals Requires Real-World Data Pharma ads face uncertainty with fading third-party cookies. Adapting to cookieless marketing means integrating real-world data into all campaign phases, demanding close collaboration and reliance on new data sources for effective targeting. Download now. Download now.

Marketing 52

Marketing Pharmaceuticals 52

Common Sense for Drug Policy Blog

FEBRUARY 14, 2024

Nitazenes in the Global Drug Market "Highly potent synthetic opioids have not played such a prominent role in rising deaths among people who use drugs in the UK. Global drug markets are, however, rapidly evolving. 3 In the UK, nitazenes have been detected in substances sold as other opioids, benzodiazepines, and cannabis products.

Marketing 52

Marketing Drugs Pharmaceuticals Production 52

BioPharma Drive: Drug Pricing

OCTOBER 23, 2023

Effective marketing measurement requires objectivity, connected data, transparency, a track record of innovation and a proven ability to execute.

Marketing 106

Marketing 106

Drug Patent Watch

AUGUST 8, 2023

A recent study explores the landscape of authorized generics in the United States pharmaceutical market. Authorized generics are brand-name drugs that are marketed without their original branding.

Marketing 96

Marketing Pharmaceuticals Drugs 96

Perficient: Drug Development

DECEMBER 14, 2023

Recently, Perficient hosted a roundtable discussion with marketing leaders from some of the top organizations from various industries. As CRM software expanded into vast data management platforms encompassing marketing, sales, and service, it lost its initial focus.

Marketing 52

Marketing Production 52